High Serum ALP Level Is Associated With Increased Risk of Denosumab-Related Hypocalcemia in Patients With Bone Metastases From Solid Tumors
Endocrine Journal - Japan
doi 10.1507/endocrj.ej16-0003
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Japan Endocrine Society